Relief Therapeutics Holding AG at its Extraordinary General Meeting held on January 28, 2022 approved election of Michelle Lock as new member of the Board of Directors. Michelle Lock, who until recently, was Senior Vice President and Head of Europe and International at Acceleron Pharma Inc, was elected as a new member of the Board of Directors, for a term of office extending until completion of the 2022 Annual General Meeting. In addition to her tenure at Acceleron, Lock has built a wealth of strategic and operational expertise from prior positions at Sage Therapeutics and over 20 years at Bristol-Myers Squibb.